EUTM file information

018706323

ARC-SparX


May 19, 2022

Trademark Summary

The trademark application ARC-SparX was filed by Arcellx, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 22, 2022, and still open for oppositions.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Biological preparations for the treatment of cancer using genetically engineered cells
    2. Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands
    3. Pharmaceutical preparations for the purpose of binding ligands using receptors
    4. Pharmaceutical preparations for immunotherapy using genetically engineered cells.
Trademarkers